Chest

Article	Citations
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019	470
The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic	463
Cross-Sectional Studies	439
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China	427
Antithrombotic Therapy for VTE Disease	349
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019	335
Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection	296
Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1	244
Hospital-Acquired Infections in Critically Ill Patients With COVID-19	219
Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Allocation	210
Executive Summary	206
Persistent Exertional Intolerance After COVID-19	185
Characterization of Severe Asthma Worldwide	160
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma	156
Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19	152
Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019	140
Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing	140
Fluid Response Evaluation in Sepsis Hypotension and Shock	139
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019	135
Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza	134
Sample Size Estimation in Clinical Research	133
Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension	133
Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma	132
The Use of Bronchoscopy During the Coronavirus Disease 2019 Pandemic	130
Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome	129

Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis	126
Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes	125
High-Flow, Noninvasive Ventilation and Awake (Nonintubation) Proning in Patients With Coronavirus Disease 2019 With Respiratory Failure	123
Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases	122
Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis	121
Robotic Bronchoscopy for Peripheral Pulmonary Lesions	120
Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU	112
Screening for Lung Cancer	111
Eosinophilic and Noneosinophilic Asthma	111
Disparities in Sleep Health and Potential Intervention Models	110
Medical Education During the COVID-19 Pandemic	108
Physical and Social Environment Relationship With Sleep Health and Disorders	106
The Coronavirus Disease 2019 Pandemic’s Effect on Critical Care Resources and Health-Care Providers	105
The Evolving Landscape of e-Cigarettes	104
Combined Treatment With Hydrocortisone, Vitamin C, and Thiamine for Sepsis and Septic Shock	104
Treatment of Community-Acquired Pneumonia in Immunocompromised Adults	101
Diagnosis and Evaluation of Hypersensitivity Pneumonitis	99
The Sleep Apnea-Specific Hypoxic Burden Predicts Incident Heart Failure	91
Pulmonary Thrombosis and Thromboembolism in COVID-19	91
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis	88
Sensitivity and Safety of Electromagnetic Navigation Bronchoscopy for Lung Cancer Diagnosis	88
Chest CT Imaging Signature of Coronavirus Disease 2019 Infection	86
Perioperative Management of Antithrombotic Therapy	85
Preliminary Findings on Control of Dispersion of Aerosols and Droplets During High-Velocity Nasal Insufflation Therapy Using a Simple Surgical Mask	83
Effect of Intermittent or Continuous Feed on Muscle Wasting in Critical Illness	83
Use of Tracheostomy During the COVID-19 Pandemic	80
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic	77
Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions	77
Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits	76
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism	74
Chest CT in COVID-19 at the ED: Validation of the COVID-19 Reporting and Data System (CO-RADS) and CT Severity Score	74
Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype	74
Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units	72
Mortality Risk Prediction in Amyopathic Dermatomyositis Associated With Interstitial Lung Disease	71
VTE in ICU Patients With COVID-19	71
Using Causal Diagrams to Improve the Design and Interpretation of Medical Research	71
Postmortem Lung Findings in a Patient With Asthma and Coronavirus Disease 2019	71
Lower vs Higher Fluid Volumes During Initial Management of Sepsis	70
Treatment of Mycobacterium abscessus Pulmonary Disease	68
Right Ventricular Dysfunction in Early Sepsis and Septic Shock	66
Feasibility of a 5G-Based Robot-Assisted Remote Ultrasound System for Cardiopulmonary Assessment of Patients With Coronavirus Disease 2019	66
Frequency, Risk Factors, Clinical Characteristics, and Outcomes of Spontaneous Pneumothorax in Patients With Coronavirus Disease 2019	66
Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and Mortality	66
Effect of Different Probes and Expertise on the Interpretation Reliability of Point-of-Care Lung Ultrasound	65
Fatigue Symptoms During the First Year Following ARDS	65
Efficacy of CPAP for Improvements in Sleepiness, Cognition, Mood, and Quality of Life in Elderly Patients With OSA	64
Standardized Definitions of Bleeding After Transbronchial Lung Biopsy	62
Update on Persistent Excessive Daytime Sleepiness in OSA	61
The Minimal Effect of Zinc on the Survival of Hospitalized Patients With COVID-19	60
Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm	59

Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic	58
Acetazolamide for OSA and Central Sleep Apnea	58
Symptoms of Mental Health Disorders in Critical Care Physicians Facing the Second COVID-19 Wave	58
Managing Chronic Cough as a Symptom in Children and Management Algorithms	57
A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis	57
Safety of Ibuprofen in Patients With COVID-19	57
Machine Learning and Prediction of All-Cause Mortality in COPD	57
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer	56
Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases	56
The Impact of Asthma on Mortality in Patients With COVID-19	55
Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic	55
Sensitivity of Radial Endobronchial Ultrasound-Guided Bronchoscopy for Lung Cancer in Patients With Peripheral Pulmonary Lesions	55
Age and Sex Disparities in Adherence to CPAP	54
Lung Cancer Screening Rates During the COVID-19 Pandemic	54
Projecting Long-term Health and Economic Burden of COPD in the United States	54
Variability and Misclassification of Sleep Apnea Severity Based on Multi-Night Testing	54
A Novel Coronavirus (COVID-19) Outbreak	54
The Usefulness of Chest CT Imaging in Patients With Suspected or Diagnosed COVID-19	54
Racial Bias in Pulse Oximetry Measurement Among Patients About to Undergo Extracorporeal Membrane Oxygenation in 2019-2020	53
Addressing Race in Pulmonary Function Testing by Aligning Intent and Evidence With Practice and Perception	53
Pulmonary Hypertension in Patients With COPD	53
Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors	53
Thromboprophylaxis in Patients With COVID-19	52
Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic	52
Relationship Between CPAP Termination and All-Cause Mortality	52
Risk Factors for Invasive Candida Infection in Critically Ill Patients	51
Lung Transplantation for Patients With COVID-19	51
Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019	51
Prognostic Value of Lung Ultrasound B-Lines in Systemic Sclerosis	50
Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD	50
Prone and Lateral Positioning in Spontaneously Breathing Patients With COVID-19 Pneumonia Undergoing Noninvasive Helmet CPAP Treatment	50
The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease	49
Long-Term Noninvasive Ventilation in the Geneva Lake Area	49
Association Between Nocturnal Hypoxemia and Cancer Incidence in Patients Investigated for OSA	49
Male Sex, Severe Obesity, Older Age, and Chronic Kidney Disease Are Associated With COVID-19 Severity and Mortality in New York City	48
Randomized Controlled Trials	48
Effect of Ultrashort-Acting β-Blockers on Mortality in Patients With Sepsis With Persistent Tachycardia Despite Initial Resuscitation	47
The Predictive Value of Lung Ultrasound Scores in Developing Bronchopulmonary Dysplasia	47
Sleep and Delirium in Adults Who Are Critically Ill	47
Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype	47
Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia	47
Tobacco Smoking and Risk for Pulmonary Fibrosis	47
A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY	46
Reboxetine Plus Oxybutynin for OSA Treatment	46
Bronchodilator Response Assessed by the Forced Oscillation Technique Identifies Poor Asthma Control With Greater Sensitivity Than Spirometry	45
Air Pollution and Asthma	45
Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates	45
Neonatal Lung Ultrasound and Surfactant Administration	44
Respiratory Disease and Lower Pulmonary Function as Risk Factors for Dementia	44
Cohort Studies	44
A Systematic Review of the Effect of Delayed Appropriate Antibiotic Treatment on the Outcomes of Patients With Severe Bacterial Infections	44
Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP	44
Senotherapy	44
Insights From Invasive Cardiopulmonary Exercise Testing of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	43
Artificial Stone Silicosis	43
The Burden of Community-Acquired Pneumonia Requiring Admission to ICU in the United States	43
Vaping-Related Acute Parenchymal Lung Injury	42
Epidemiology of Adult Pleural Disease in the United States	42
Changes in Pediatric ICU Utilization and Clinical Trends During the Coronavirus Pandemic	42
Angiotensin II Infusion for Shock	41
Teaching Clinical Reasoning and Critical Thinking	41
IgA Antibodies Directed Against Citrullinated Protein Antigens Are Elevated in Patients With Idiopathic Pulmonary Fibrosis	40
Assessing the Physiologic Endotypes Responsible for REM- and NREM-Based OSA	40
Sleep Apnea and Insomnia	40
Comparative Effectiveness of Robotic-Assisted Surgery for Resectable Lung Cancer in Older Patients	40
Higher vs Lower Oxygenation Strategies in Acutely Ill Adults	40
Gaps in COPD Guidelines of Low- and Middle-Income Countries	40
Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren’s	40
Progesterone in Addition to Standard of Care vs Standard of Care Alone in the Treatment of Men Hospitalized With Moderate to Severe COVID-19	40
Impact of Obesity in Critical Illness	40
Actions Taken by US Hospitals to Prepare for Increased Demand for Intensive Care During the First Wave of COVID-19	39
Incidence and Location of Atelectasis Developed During Bronchoscopy Under General Anesthesia	39
Frailty in Patients With Lung Cancer	39
Machine Learning Characterization of COPD Subtypes	39
An Evaluation of Diagnostic Yield From Bronchoscopy	39
Race Correction and Spirometry	39
Systematic Review of Ozone Effects on Human Lung Function, 2013 Through 2020	39
A Validation Study of Four Different Cluster Analyses of OSA and the Incidence of Cardiovascular Mortality in a Hispanic Population	39
Post-ICU COVID-19 Outcomes	38
Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States	38

Risk Factors for Dysphagia in ICU Patients After Invasive Mechanical Ventilation	38
Racial Differences in Adherence to Lung Cancer Screening Follow-up	38
Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis	38
Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019	38
Global Impact of Respiratory Disease	37
Rapid Design and Implementation of Post-COVID-19 Clinics	37
Guideline-Recommended Lung Cancer Screening Adherence Is Superior With a Centralized Approach	36
The Spectrum of Sleep Disorders in Parkinson Disease	36
Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project	36
Performance and Interpretation of Invasive Hemodynamic Exercise Testing	36
Safety and Efficacy of Dexmedetomidine in Acutely Ill Adults Requiring Noninvasive Ventilation	35
Family Presence for Critically Ill Patients During a Pandemic	35
C-reactive Protein and Risk of OSA in Four US Cohorts	35
Novel Machine Learning Can Predict Acute Asthma Exacerbation	35
A Randomized Trial of Initiation of Chronic Noninvasive Mechanical Ventilation at Home vs In-Hospital in Patients With Neuromuscular Disease and Thoracic Cage Disorder	35
International Severe Asthma Registry	35
Providing Outpatient Telehealth Services in the United States	35
Endobronchial Valves for the Treatment of Advanced Emphysema	35
Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism	35
Meta-Analysis	35
Neurological Pupil index for Early Prognostication After Venoarterial Extracorporeal Membrane Oxygenation	35
Clinical and Genetic Spectrum of Children With Primary Ciliary Dyskinesia in China	35
Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents	34
High-Flow Nasal Cannula in the Immediate Postoperative Period	34
Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation	34
Recognition and Management of Myositis-Associated Rapidly Progressive Interstitial Lung Disease	34
Safety and Efficacy of Bronchoscopy in Critically Ill Patients With Coronavirus Disease 2019	34
Neighborhood Disadvantage and Lung Cancer Incidence in Ever-Smokers at a Safety Net Health-Care System	34
A Call to Action	34
The Influence of the COVID-19 Pandemic on ICU Organization, Care Processes, and Frontline Clinician Experiences	34
Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry	34
Regional Planning for Extracorporeal Membrane Oxygenation Allocation During Coronavirus Disease 2019	34
Diagnostic Outcomes and Safety of Cryobiopsy Added to Conventional Sampling Methods	33
Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19	33
Minimal Inhibitory Concentration of Clofazimine Among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment Outcome	33
Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD	33
Differences in Clinical Characteristics and Outcomes Between Men and Women With Idiopathic Pulmonary Fibrosis	33
Using Cardiopulmonary Exercise Testing to Understand Dyspnea and Exercise Intolerance in Respiratory Disease	33
Development and Prospective Validation of a Deep Learning Algorithm for Predicting Need for Mechanical Ventilation	33
Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction	33
Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis	32
Undiagnosed OSA May Significantly Affect Outcomes in Adults Admitted for COPD in an Inner-City Hospital	32
Effects of Compliance With the Early Management Bundle (SEP-1) on Mortality Changes Among Medicare Beneficiaries With Sepsis	32
Diagnostic Accuracy of Thoracic Ultrasonography to Differentiate Transudative From Exudative Pleural Effusion	32
Protein Biomarkers for COPD Outcomes	32
Ventilatory Mechanics in Early vs Late Intubation in a Cohort of Coronavirus Disease 2019 Patients With ARDS	32
Inferior Vena Cava Filters	32
The Usefulness of the Rapid Shallow Breathing Index in Predicting Successful Extubation	31
CT Findings and Patterns of e-Cigarette or Vaping Product Use-Associated Lung Injury	31
The Impact of Alternative Approaches to Diagnostic Yield Calculation in Studies of Bronchoscopy	31
Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers	31
Patterns of Use of Adjunctive Therapies in Patients With Early Moderate to Severe ARDS	31
Management for the Drowning Patient	31
A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis	31
When the Game Changes	31
Clinical Presentation and Outcomes of Acute Pericarditis in a Large Urban Hospital in the United States of America	31
Utilization of Lung Cancer Screening in the Medicare Fee-for-Service Population	30
Normative Peak Cardiopulmonary Exercise Test Responses in Canadian Adults Aged ≥40 Years	30
Global Physiology and Pathophysiology of Cough	30
Surfactant Protein D Is Associated With Severe Pediatric ARDS, Prolonged Ventilation, and Death in Children With Acute Respiratory Failure	30
Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis	30
Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation	30
Prevention of Asthma	30
Cardiorespiratory Progression Over 5 Years and Role of Corticosteroids in Duchenne Muscular Dystrophy	30
A Geographic Analysis of Racial Disparities in Use of Pulmonary Rehabilitation After Hospitalization for COPD Exacerbation	29
Diagnosing EVALI in the Time of COVID-19	29
Prognostic Value of 6-Min Walk Test to Predict Postoperative Cardiopulmonary Complications in Patients With Non-small Cell Lung Cancer	29
Use of Handheld Point-of-Care Ultrasound in Emergency Airway Management	29
Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia	29
Association of Triglyceride-Glucose Index and Lung Health	29
The Clinical Use of Lung MRI in Cystic Fibrosis	29
Clinical Evaluation of Deployed Military Personnel With Chronic Respiratory Symptoms	29
Severe Pulmonary Hypertension in COPD	29
Incidence, Risk Factors, and Effects on Outcome of Ventilator-Associated Pneumonia in Patients With Traumatic Brain Injury	29
Dyspnea Postpulmonary Embolism From Physiological Dead Space Proportion and Stroke Volume Defects During Exercise	29
Impact of Right Ventricular Dysfunction on Short-term and Long-term Mortality in Sepsis	29
It Takes a Village…	29
The Effect of Tumor Size and Histologic Findings on Outcomes After Segmentectomy vs Lobectomy for Clinically Node-Negative Non-Small Cell Lung Cancer	28
Mortality Trends of Idiopathic Pulmonary Fibrosis in the United States From 2004 Through 2017	28
Early Changes Over Time in the Radiographic Assessment of Lung Edema Score Are Associated With Survival in ARDS	28
Extremes of Age Decrease Survival in Adults After Lung Transplant	28
Mixed Ventilatory Defects in Pulmonary Sarcoidosis	28
Trends and Geographic Variation in Acute Respiratory Failure and ARDS Mortality in the United States	28
Effect of Early Balanced Crystalloids Before ICU Admission on Sepsis Outcomes	28
The PERT Concept	28
Effect of Olfactory Stimulation by L-Menthol on Laboratory-Induced Dyspnea in COPD	28
Multisystem Inflammatory Syndrome in Adults	28
A Behavior Change Intervention Aimed at Increasing Physical Activity Improves Clinical Control in Adults With Asthma	27
Lung Ultrasound for Patients With Coronavirus Disease 2019 Pulmonary Disease	27
Luminal Plugging on Chest CT Scan	27
Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease	27
International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline	27
VTE Prophylaxis in Critically Ill Adults	27
A National Strategy for Ventilator and ICU Resource Allocation During the Coronavirus Disease 2019 Pandemic	27
The Association Between Air Pollution and Hospitalization of Patients With Idiopathic Pulmonary Fibrosis in Chile	27